Altimmune (ALT) Depreciation & Amortization - Total (2012 - 2017)
Powered by 
Analysis
Altimmune (ALT) Depreciation & Amortization - Total (2012 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Altimmune | 618.45 Mn | 618.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 33,007.00 |
| Dec 31, 2016 | 33,066.00 |
| Sep 30, 2016 | 32,235.00 |
| Jun 30, 2016 | 40,435.00 |
| Mar 31, 2016 | 37,701.00 |
| Dec 31, 2015 | 32,806.00 |
| Sep 30, 2015 | 35,005.00 |
| Jun 30, 2015 | 36,687.00 |
| Mar 31, 2015 | 37,106.00 |
| Dec 31, 2014 | 36,686.00 |
| Sep 30, 2014 | 37,125.00 |
| Jun 30, 2014 | 36,208.00 |
| Mar 31, 2014 | 39,939.00 |
| Dec 31, 2013 | 43,438.00 |
| Sep 30, 2013 | 44,593.00 |
| Jun 30, 2013 | 41,854.00 |
| Mar 31, 2013 | 52,602.00 |
| Dec 31, 2012 | 69,105.00 |
| Sep 30, 2012 | 72,453.00 |